357 related articles for article (PubMed ID: 25407893)
1. Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.
Zhan JK; Tan P; Wang YJ; Wang Y; He JY; Tang ZY; Huang W; Liu YS
Cardiovasc Diabetol; 2014 Nov; 13():153. PubMed ID: 25407893
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs.
Zhan JK; Wang YJ; Wang Y; Tang ZY; Tan P; Huang W; Liu YS
Int J Cardiol; 2015 Jun; 189():188-93. PubMed ID: 25897902
[TBL] [Abstract][Full Text] [Related]
3. Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression.
Liu GY; Liang QH; Cui RR; Liu Y; Wu SS; Shan PF; Yuan LQ; Liao EY
Endocrinology; 2014 Feb; 155(2):558-67. PubMed ID: 24248461
[TBL] [Abstract][Full Text] [Related]
4. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
[TBL] [Abstract][Full Text] [Related]
5. RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells.
Yuan LQ; Zhu JH; Wang HW; Liang QH; Xie H; Wu XP; Zhou H; Cui RR; Sheng ZF; Zhou HD; Zhu X; Liu GY; Liu YS; Liao EY
PLoS One; 2011; 6(12):e29037. PubMed ID: 22194983
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway.
Chen K; Jin HJ; Wu ZH; Zhang BF; Wu J; Huang ZY; Huang YP; Lu XW; Zheng XT
Mol Med; 2024 May; 30(1):58. PubMed ID: 38720283
[TBL] [Abstract][Full Text] [Related]
7. Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling.
Lee J; Hong SW; Kim MJ; Kwon H; Park SE; Rhee EJ; Lee WY
Biochem Biophys Res Commun; 2020 Sep; 530(2):374-380. PubMed ID: 32800550
[TBL] [Abstract][Full Text] [Related]
8. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M
J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764
[TBL] [Abstract][Full Text] [Related]
9. Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells.
Shan PF; Lu Y; Cui RR; Jiang Y; Yuan LQ; Liao EY
PLoS One; 2011 Mar; 6(3):e17938. PubMed ID: 21437254
[TBL] [Abstract][Full Text] [Related]
10. MiR-26a regulates vascular smooth muscle cell calcification in vitro through targeting CTGF.
Wu W; Shang YQ; Dai SL; Yi F; Wang XC
Bratisl Lek Listy; 2017; 118(8):499-503. PubMed ID: 29050490
[TBL] [Abstract][Full Text] [Related]
11. High Phosphate-Induced Calcification of Vascular Smooth Muscle Cells is Associated with the TLR4/NF-κb Signaling Pathway.
Zhang D; Bi X; Liu Y; Huang Y; Xiong J; Xu X; Xiao T; Yu Y; Jiang W; Huang Y; Zhang J; Zhang B; Zhao J
Kidney Blood Press Res; 2017; 42(6):1205-1215. PubMed ID: 29227975
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway.
Liang QH; Jiang Y; Zhu X; Cui RR; Liu GY; Liu Y; Wu SS; Liao XB; Xie H; Zhou HD; Wu XP; Yuan LQ; Liao EY
PLoS One; 2012; 7(4):e33126. PubMed ID: 22514603
[TBL] [Abstract][Full Text] [Related]
13. The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells.
Zhan JK; Wang YJ; Wang Y; Wang S; Tan P; Huang W; Liu YS
Can J Cardiol; 2014 May; 30(5):568-75. PubMed ID: 24518659
[TBL] [Abstract][Full Text] [Related]
14. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.
Nie B; Zhang SY; Guan SM; Zhou SQ; Fang X
Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells.
Liu N; Liu JT; Ji YY; Lu PP
Life Sci; 2010 Sep; 87(11-12):367-74. PubMed ID: 20670634
[TBL] [Abstract][Full Text] [Related]
16. The function and meaning of receptor activator of NF-κB ligand in arterial calcification.
Nie B; Zhou SQ; Fang X; Zhang SY; Guan SM
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):666-671. PubMed ID: 26489619
[TBL] [Abstract][Full Text] [Related]
17. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.
Xie H; Xie PL; Wu XP; Chen SM; Zhou HD; Yuan LQ; Sheng ZF; Tang SY; Luo XH; Liao EY
Cardiovasc Res; 2011 Nov; 92(2):296-306. PubMed ID: 21750093
[TBL] [Abstract][Full Text] [Related]
18. TLR4/NF-κB/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells.
Song Y; Hou M; Li Z; Luo C; Ou JS; Yu H; Yan J; Lu L
Eur J Pharmacol; 2017 Jan; 794():45-51. PubMed ID: 27876618
[TBL] [Abstract][Full Text] [Related]
19. Puerarin attenuates calcification of vascular smooth muscle cells.
Lu Q; Xiang DX; Yuan HY; Xiao Y; Yuan LQ; Li HB
Am J Chin Med; 2014; 42(2):337-47. PubMed ID: 24707866
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.
Osako MK; Nakagami H; Shimamura M; Koriyama H; Nakagami F; Shimizu H; Miyake T; Yoshizumi M; Rakugi H; Morishita R
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1287-96. PubMed ID: 23580147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
